Join us at BPI East in Boston, Booth 831!
Dr. Michael Chen, CEO & Co-founder of GBB, will be presenting:
Topic: Advantages of AI + Site-specific Integration Cell Line Development (AlfaCell) in CMC Bioprocessing, Bi-specific Antibody and ADC Development
Date: Wednesday, 17 September
Time: 3:15 pm - 3:45 pm, ET
Session: Cell Line Development & Engineering
Don’t miss this chance to gain fresh insights into AI-powered cell line development
